Update on the Pathogenesis, Virulence, and Treatment of Candida auris
- PMID: 36329818
- PMCID: PMC9620957
- DOI: 10.20411/pai.v7i2.535
Update on the Pathogenesis, Virulence, and Treatment of Candida auris
Abstract
Candida auris is an emerging, multidrug resistant fungal pathogen that causes considerable morbidity and mortality. First identified in Japan in 2009, it has since been reported in more than 40 countries. C. auris can persist for long periods on different environmental surfaces as well as the skin. Clinical isolates are typically resistant to commonly prescribed antifungal drugs. Increasingly recognized as a cause of infections and outbreaks in nosocomial settings, C. auris is difficult to identify using traditional microbiological methods. One of the main reasons for the ongoing spread of C. auris is the multitude of virulence factors it possesses and uses against its human host that enables fungal persistence on the skin surface. Yet, many of the virulence mechanismsare unknown or remain incompletely understood. In this review, we summarize the evolution of virulence of C. auris, offer recommendations for combating this important human pathogen, and suggest directions for further research.
Keywords: Candida auris; antifungal resistance; fungemia; immune responses; virulence.
© Pathogens and Immunity 2022.
Conflict of interest statement
Dr. Mahmoud Ghannoum serves as a Senior Editor and Dr. Richard Watkins serves as an Associate Editor for Pathogens and Immunity. Dr. Watkins serves as a paid consultant to BioMe'rieux and has received research funding from Allergan. The authors report no other competing financial interests.
Figures
References
-
- Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4. doi: 10.1111/j.1348-0421.2008.00083.x. PubMed PMID: 19161556. - DOI - PubMed
-
- Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. doi: 10.15620/cdc:82532. Available from: https://stacks.cdc.gov/view/cdc/82532. - DOI
-
- Allert S, Schulz D, Kammer P, Grossmann P, Wolf T, Schauble S, Panagiotou G, Brunke S, Hube B. From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris. Virulence. 2022;13(1):191–214. doi: 10.1080/21505594.2022.2026037. PubMed PMID: 35142597; PMCID: PMC8837256. - DOI - PMC - PubMed
-
- Chow NA, Munoz JF, Gade L, Berkow EL, Li X, Welsh RM, Forsberg K, Lockhart SR, Adam R, Alanio A, Alastruey-Izquierdo A, Althawadi S, Arauz AB, Ben-Ami R, Bharat A, Calvo B, Desnos-Ollivier M, Escandon P, Gardam D, Gunturu R, Heath CH, Kurzai O, Martin R, Litvintseva AP, Cuomo CA. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses. mBio. 2020;11(2):e03364–19. doi: 10.1128/mBio.03364-19. PubMed PMID: 32345637; PMCID: PMC7188998. - DOI - PMC - PubMed
-
- Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S, Maor Y, Tarabia J, Schechner V, Adler A, Finn T. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis. 2017;23(1):195–203. doi: 10.3201/eid2302.161486. PubMed PMID: 28098529; PMCID: PMC5324804. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources